A Nucleoprotein-Enriched Diet Suppresses Dopaminergic Neuronal Cell Loss and Motor Deficit in Mice with MPTP-Induced Parkinson’s Disease

Journal of Molecular Neuroscience

Volumn 55, Issue 3, 2015, Pages 803-811

  Kiriyama, Keisuke ^a   Ohtaki, Hirokazu ^a   Kobayashi, Natsuki ^a   Murai, Norimitsu ^a   Matsumoto, Minako ^a   Sasaki, Shun ^a   Sawa, Chika ^a   Satoh, Kazue ^a   Matsunaga, Masaji ^b   Shioda, Seiji ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Gene Trophology Research Institute   (Japan)

Author keywords

Dopaminergic neuron; Nucleoprotein; Oxidative stress; Parkinson s disease

Indexed keywords

ANTIBODY; IBA1 ANTIBODY; NUCLEOPROTEIN; SUPEROXIDE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; CYTOCHROME C OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CONTROLLED STUDY; COX8B GENE; DIET SUPPLEMENTATION; DOPAMINERGIC NERVE CELL; ELECTRON TRANSPORT; GENE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; LOCOMOTION; MALE; MOTOR DYSFUNCTION; MOUSE; MPTP-INDUCED PARKINSONISM; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN INTAKE; SALMON; UPREGULATION; ANIMAL; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; GENETICS; MESENCEPHALON; METABOLISM; MPTP POISONING;

ANIMALIA; MUS;

ANIMALS; DIETARY SUPPLEMENTS; DOPAMINERGIC NEURONS; ELECTRON TRANSPORT COMPLEX IV; LOCOMOTION; MALE; MESENCEPHALON; MICE; MICE, INBRED C57BL; MPTP POISONING; NUCLEOPROTEINS; SUPEROXIDES; TYROSINE 3-MONOOXYGENASE;

EID: 84922251229     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-014-0432-2     Document Type: Article

References (26)

1. Bindokas VP, Jordán J, Lee CC, Miller RJ (1996) Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J Neurosci 16(4):1324–1336
2. Chen TH, Wang MF, Liang YF, Komatsu T, Chan YC, Chung SY, Yamamoto S (2000) A nucleoside-nucleotide mixture may reduce memory deterioration in old senescence-accelerated mice. J Nutr 130:3085–3089
3. Chung YC, Kim SR, Park JY, Chung ES, Park KW, Won SY, Bok E, Jin M, Park ES, Yoon SH, Ko HW, Kim YS, Jin BK (2011) Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation. Neuropharmacology 60(6):963–974
4. Dauer W, Przedborski S (2003) Parkinson’s disease: mechanisms and models. Neuron 39(6):889–909
5. Goldberg NR, Hampton T, McCue S, Kale A, Meshul CK (2011) Profiling changes in gait dynamics resulting from progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal lesioning. J Neurosci Res 89(10):1698–1706
6. Hernandez TD, Schallert T (1988) Seizures and recovery from experimental brain damage. Exp Neurol 102(3):318–324
7. Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson’s disease: a target for neuroprotection? Lancet Neurol 8(4):382–397
8. Hori M, Nakamachi T, Rakwal R, Shibato J, Nakamura K, Wada Y, Tsuchikawa D, Yoshikawa A, Tamaki K, Shioda S (2012) Unraveling the ischemic brain transcriptome in a permanent middle cerebral artery occlusion mouse model by DNA microarray analysis. Dis Model Mech 5(2):270–283
9. Khan MM, Kempuraj D, Thangavel R, Zaheer A (2013) Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol. Neurochem Int 62(4):379–388
10. Langston JW (1996) The etiology of Parkinson’s disease with emphasis on the MPTP story. Neurology 47(6 Suppl 3):S153–S160
11. Matsunaga M, Ohtaki H, Takaki A, Iwai Y, Yin L, Mizuguchi H, Miyake T, Usumi K, Shioda S (2003) Nucleoprotamine diet derived from salmon soft roe protects mouse hippocampal neurons from delayed cell death after transient forebrain ischemia. Neurosci Res 47(3):269–276
12. Meredith GE, Totterdell S, Petroske E, Santa CK, Callison RC, Lau YS (2002) Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson’s disease. Brain Res 956(1):156–165
13. Mosley RL, Hutter-Saunders JA, Stone DK, Gendelman HE (2012) Inflammation and adaptive immunity in Parkinson’s disease. Cold Spring Harb Perspect Med 2(1):a009381
14. Murakami K, Kondo T, Kawase M, Li Y, Sato S, Chen SF, Chan PH (1998) Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci 18(1):205–213
15. Ohtaki H, Takeda T, Dohi K, Yofu S, Nakamachi T, Satoh K, Hiraizumi Y, Miyaoka H, Matsunaga M, Shioda S (2007) Increased mitochondrial DNA oxidative damage after transient middle cerebral artery occlusion in mice. Neurosci Res 58(4):349–355
16. Ohtaki H, Yofu S, Nakamachi T, Satoh K, Shimizu A, Mori H, Sato A, Iwakura Y, Matsunaga M, Shioda S (2010) Nucleoprotein diet ameliorates arthritis symptoms in mice transgenic for human T-cell leukemia virus type I (HTLV-1). J Clin Biochem Nutr 46(2):93–104
17. Seehafer SS, Pearce DA (2006) You say lipofuscin, we say ceroid: defining autofluorescent storage material. Neurobiol Aging 27(4):576–588
18. Singer TP, Castagnoli N, Ramsay RR, Trevor AJ (1987) Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurochem 49(1):1–8
19. Speciale SG (2002) MPTP: insights into Parkinsonian neurodegeneration. Neurotoxicol Teratol 24(5):607–620
20. Sudo N, Aiba Y, Takaki A, Tanaka K, Yu XN, Oyama N, Koga Y, Kubo C (2000) Dietary nucleic acids promote a shift in Th1/Th2 balance toward Th1-dominant immunity. Clin Exp Allergy 30(7):979–987
21. Tanaka S, Ishii A, Ohtaki H, Shioda S, Yoshida T, Numazawa S (2013) Activation of microglia induces symptoms of Parkinson’s disease in wild-type, but not in IL-1 knockout mice. J Neuroinflammation 10:143
22. Taylor JM, Main BS, Crack PL (2013) Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson’s disease. Neurochem Int 62(5):803–819
23. Tipton KF, Singer TP (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem 61(4):1191–1206
24. Turski L, Bressler K, Rettig KJ, Löschmann PA, Wachtel H (1991) Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349(6308):414–418
25. Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H, Przedborski S (2003) NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s disease. Proc Natl Acad Sci U S A 100(10):6145–6150
26. Yofu S, Ogawa T, Nakamachi T, Satoh K, Shimizu A, Matsunaga M, Shioda S (2010) Nucleoprotein diet prevents LPS-induced liver injury in mice. Jpn J Appl Physiol 40(3):137–143